Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oral prolonged-release ketamine in treatment-resistant depression - A double-blind randomized placebo-controlled multicentre trial of KET01, a novel ketamine formulation - Clinical and safety results.
Colla M, Offenhammer B, Scheerer H, Kronenberg G, Vetter S, Mutschler J, Mikoteit T, Bankwitz A, Adank A, Schaekel L, Eicher C, Brühl AB, Seifritz E. Colla M, et al. J Psychiatr Res. 2024 May;173:124-130. doi: 10.1016/j.jpsychires.2024.03.002. Epub 2024 Mar 4. J Psychiatr Res. 2024. PMID: 38522166 Clinical Trial.
Exploring the Relationship between Adherence to Therapy, Treatment Acceptability, and Clinical Outcomes in Adults with Attention-Deficit/Hyperactivity Disorder: Results from the COMPAS Multicenter Randomized Controlled Trial.
López-Pinar C, Rosen H, Selaskowski B, Staerk C, Jans T, Retz W, Retz-Junginger P, Roesler M, Sobanski E, Huss M, Matthies S, Tebartz van Elst L, Berger M, Jacob C, Kis B, Colla M, Alm B, Abdel-Hamid M, Martínez-Sanchís S, Carbonell-Vayá E, Lux S, Philipsen A. López-Pinar C, et al. Among authors: colla m. Psychother Psychosom. 2024;93(1):46-64. doi: 10.1159/000532043. Epub 2023 Dec 22. Psychother Psychosom. 2024. PMID: 38142690 Clinical Trial.
Bright light therapy versus physical exercise to prevent co-occurring depression in adolescents and young adults with attention-deficit/hyperactivity disorder: a multicentre, three-arm, randomised controlled, pilot phase-IIa trial.
Mayer JS, Kohlhas L, Stermann J, Medda J, Brandt GA, Grimm O, Pawley AD, Asherson P, Sanchez JP, Richarte V, Bergsma D, Koch ED, Muntaner-Mas A, Ebner-Priemer UW, Kieser M, Retz W, Ortega FB, Colla M, Buitelaar JK, Kuntsi J, Ramos-Quiroga JA, Reif A, Freitag CM. Mayer JS, et al. Among authors: colla m. Eur Arch Psychiatry Clin Neurosci. 2024 Apr 16. doi: 10.1007/s00406-024-01784-1. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 38627266
Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Randomized Clinical Trial.
Philipsen A, Jans T, Graf E, Matthies S, Borel P, Colla M, Gentschow L, Langner D, Jacob C, Groß-Lesch S, Sobanski E, Alm B, Schumacher-Stien M, Roesler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Heinrich V, Huss M, Kornmann C, Bürger A, Perlov E, Ihorst G, Schlander M, Berger M, Tebartz van Elst L; Comparison of Methylphenidate and Psychotherapy in Adult ADHD Study (COMPAS) Consortium. Philipsen A, et al. Among authors: colla m. JAMA Psychiatry. 2015 Dec;72(12):1199-210. doi: 10.1001/jamapsychiatry.2015.2146. JAMA Psychiatry. 2015. PMID: 26536057 Clinical Trial.
Exploring the efficacy of dialectical behaviour therapy and methylphenidate on emotional comorbid symptoms in adults with attention Deficit/Hyperactivity disorder: Results of the COMPAS multicentre randomised controlled trial.
López-Pinar C, Selaskowski B, Braun N, Fornés-Ferrer V, Euscher R, Matthies S, Jans T, van Elst LT, Jacob C, Huss M, Sobanski E, Retz W, Roesler M, Retz-Junginger P, Alm B, Kis B, Abdel-Hamid M, Colla M, Berger M, Lux S, Philipsen A. López-Pinar C, et al. Among authors: colla m. Psychiatry Res. 2023 Dec;330:115610. doi: 10.1016/j.psychres.2023.115610. Epub 2023 Nov 18. Psychiatry Res. 2023. PMID: 37992514 Clinical Trial.
Multimodal treatment efficacy differs in dependence of core symptom profiles in adult Attention-Deficit/Hyperactivity Disorder: An analysis of the randomized controlled COMPAS trial.
Selaskowski B, Staerk C, Braun N, Matthies S, Graf E, Colla M, Jacob C, Sobanski E, Alm B, Roesler M, Retz W, Retz-Junginger P, Kis B, Abdel-Hamid M, Huss M, Jans T, Tebartz van Elst L, Berger M, Lux S, Mayr A, Philipsen A. Selaskowski B, et al. Among authors: colla m. J Psychiatr Res. 2022 Jul;151:225-234. doi: 10.1016/j.jpsychires.2022.03.049. Epub 2022 Apr 1. J Psychiatr Res. 2022. PMID: 35500450
93 results